Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a monoclonal antibody targeting the CD70 antibody. Vorsetuzumab has anticancer activity and can enhance the macrophage-associated phagocytosis of kidney cancer cells and inhibit Burkitt lymphoma.
CAS Number:
[1165740-62-4]
Target:
SGN-70
* VAT and and shipping costs not included. Errors and price changes excepted